Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Estradiol levels in early pregnancy after different FET stimulation protocols
2020-001218-39Phase 4Completed
- Sponsor
- Herlev Hospital
- Start
- Apr 2020
- Modality
- Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of estradiol, progesterone, follicle-stimulating hormone and recombinant human chorionic gonadotrophin in female infertility (3 arms), sponsored by Herlev Hospital. Primary endpoint: Plasma estradiol and progesterone levels in early pregnancy. Started Apr 2020; status: completed.
02
Drugs
estradiolprogesteronefollicle-stimulating hormonerecombinant human chorionic gonadotrophin
03
Conditions
female infertility
Beyond the preview
Go deeper on 2020-001218-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-001218-39.